Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Histopathology of type 1 diabetes: old paradigms and new insights.

Coppieters KT, von Herrath MG.

Rev Diabet Stud. 2009;6(2):85-96. doi: 10.1900/RDS.2009.6.85. Epub 2009 Aug 10.

2.

Dioxin- and POP-contaminated sites--contemporary and future relevance and challenges: overview on background, aims and scope of the series.

Weber R, Gaus C, Tysklind M, Johnston P, Forter M, Hollert H, Heinisch E, Holoubek I, Lloyd-Smith M, Masunaga S, Moccarelli P, Santillo D, Seike N, Symons R, Torres JP, Verta M, Varbelow G, Vijgen J, Watson A, Costner P, Woelz J, Wycisk P, Zennegg M.

Environ Sci Pollut Res Int. 2008 Jul;15(5):363-93. doi: 10.1007/s11356-008-0024-1. Epub 2008 Jul 3. Review.

PMID:
18597132
3.

Early object relations into new objects.

Downey TW.

Psychoanal Study Child. 2001;56:39-67; discussion 68-75.

PMID:
12102023
4.

Surgeons: A Future Role in Clinical Trials?

Rusch VW.

Oncologist. 1997;2(3):V-VI.

PMID:
10388050
5.
6.

Beware the Medical-Industrial Complex.

Stevens CW, Glatstein E.

Oncologist. 1996;1(4):IV-V.

PMID:
10388005
7.

Vaccine therapies for the prevention of type 1 diabetes mellitus.

Petrovsky N, Silva D, Schatz DA.

Paediatr Drugs. 2003;5(9):575-82. Review.

PMID:
12956615
8.
9.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
10.

Sweetness and light: perspectives for rodent models of type 1 diabetes.

Avner PR.

Dis Model Mech. 2010 Jul-Aug;3(7-8):426-9. doi: 10.1242/dmm.004705. Epub 2010 Jun 2.

11.

New ways of insulin delivery.

Heinemann L.

Int J Clin Pract Suppl. 2010 Feb;(166):29-40. doi: 10.1111/j.1742-1241.2009.02276.x. Review.

PMID:
20377662
12.

Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.

Planas R, Pujol-Borrell R, Vives-Pi M.

Immunol Lett. 2010 Oct 30;133(2):55-61. doi: 10.1016/j.imlet.2010.08.001. Epub 2010 Aug 11. Review.

PMID:
20708640
13.

Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.

Shultz LD, Pearson T, King M, Giassi L, Carney L, Gott B, Lyons B, Rossini AA, Greiner DL.

Ann N Y Acad Sci. 2007 Apr;1103:77-89. Epub 2007 Mar 1.

PMID:
17332083
14.

The developmental origins of naïve psychology in infancy.

Poulin-Dubois D, Brooker I, Chow V.

Adv Child Dev Behav. 2009;37:55-104. Review.

PMID:
19673160
15.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
16.

Lessons on autoimmune diabetes from animal models.

Yang Y, Santamaria P.

Clin Sci (Lond). 2006 Jun;110(6):627-39. Review.

PMID:
16689681
17.

Mouse Models for Type 1 Diabetes.

Van Belle TL, Taylor P, von Herrath MG.

Drug Discov Today Dis Models. 2009 Summer;6(2):41-45.

18.

Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Driver JP, Serreze DV, Chen YG.

Semin Immunopathol. 2011 Jan;33(1):67-87. doi: 10.1007/s00281-010-0204-1. Epub 2010 Apr 28. Review.

PMID:
20424843
19.

A comprehensive review of interventions in the NOD mouse and implications for translation.

Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT.

Immunity. 2005 Aug;23(2):115-26. Review.

20.

Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse.

Beauquis J, Saravia F, Coulaud J, Roig P, Dardenne M, Homo-Delarche F, De Nicola A.

Exp Neurol. 2008 Apr;210(2):359-67. doi: 10.1016/j.expneurol.2007.11.009. Epub 2007 Nov 29.

PMID:
18190910
Items per page

Supplemental Content

Write to the Help Desk